Some studies have suggested that patients with missense PTEN mutations may have a lower risk of thyroid cancer, mutations in the promoter region of the gene may increase BC risk, and nonsense mutations may increase the risk of colorectal cancer (44, 45). Here, PTEN is linked to breast cancer.